Sweden· SE-19900914000012
Ultravist 150 mg I/ml Injektions-/infusionsvätska, lösning
A medicinal product containing iopromide, registered in Sweden by Bayer AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Iopromide
- Manufacturer
- Bayer AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer19900914000012
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Iopromide in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaULTRAVISTBayer AG, Leverkusen
- BelgiumUltravist 240 240 mg/mlBayer
- United KingdomUltravist 150 solution for injection 50ml vialsBayer Plc
- Japanイオプロミドバイエル薬品
- GermanyUltravist 300Eurocontrast Gmbh
- United StatesUltravistBayer HealthCare Pharmaceuticals Inc.
- FranceULTRAVIST 300 (300 mg d'Iode/mL), solution injectableBAYER HEALTHCARE
- FinlandUltravistBayer Oy
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Ultravist
- Belgium · Ultravist
- Bulgaria · Ултравист
- Cyprus · Ultravist 300, Ultravist 370
- Czechia · Ultravist
- Germany · Ultravist 300, Ultravist-240
- Denmark · Ultravist
- Estonia · Ultravist
- Spain · Ultravist
- France · Ultravist
- Greece · Ultravist
- Croatia · Ultravist
- Hungary · Ultravist
- Italy · Ultravist
- Lithuania · Ultravist
- Luxembourg · Ultravist
- Latvia · Ultravist
- Malta · Ultravist 370
- Netherlands · Ultravist
- Norway · Ultravist
- Poland · Ultravist 300, Ultravist 370
- Portugal · Ultravist 240, Ultravist 300
- Romania · Ultravist
- Slovenia · Ultravist
- Slovakia · Ultravist
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/493a7103-92f6-4abc-9e32-81f354f4d304 GET /v1/drugs/493a7103-92f6-4abc-9e32-81f354f4d304?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL",
"sRMP"
],
"se_npl_id": "19900914000012",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19900914000012",
"product_doc_link": "https://docetp.mpa.se/LMF/Ultravist%20solution%20for%20injection%20or%20infusion%20SmPC_09001bee807a6c14.pdf"
}See everything about iopromide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.